Exploratory analyses to guide inclusion, limitation of sample size and strengthening of endpoints in clinical stroke trials
Clinical trials for treatment of acute ischaemic stroke require large numbers of patients and are expensive to conduct. Treatment is typically administered within the first hours or days after stroke onset. Outcome is usually assessed by a single measure, the most common being the modified Rankin sc...
Main Author: | Fulton, Rachael Louise |
---|---|
Published: |
University of Glasgow
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.578587 |
Similar Items
-
Compassion and psychological adjustment following a stroke in a community sample
by: Bouquillon, Linda
Published: (2015) -
Mechanisms underlying the endogenous neuroprotection of hamartin in ischaemic stroke
by: Hadley, Gina Louise
Published: (2016) -
The natural history of stroke recurrence after first-ever stroke
by: Mohan, Keerthi Michelle
Published: (2016) -
Inclusion formation in Huntington's disease models
by: Gong, B.
Published: (2004) -
Plasma proteins and related genes in Alzheimer's disease
by: Cunningham Vardy, Emma Rachael Louise
Published: (2007)